Updates in the Management of Stage III Non-Small Cell Lung Cancer (NSCLC) - Episode 2

Biomarker Testing and the Multidisciplinary Approach in Early-Stage NSCLC

, , ,

Panelists discuss the utilization of testing and multidisciplinary approaches for testing.

EP. 1: Patient with Stage IIIB NSCLC with No Actionable Mutations and PD-L1 TPS 0%
Now Viewing
EP. 2: Biomarker Testing and the Multidisciplinary Approach in Early-Stage NSCLC

Video content above is prompted by the following:

  • Please comment on the multidisciplinary team approach – how is this implemented in your practice setting for clinical decision making in early-stage NSCLC?